ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Radical Numerics announced on Tuesday that scientists used AI-designed phages to treat a patient with a resistant E. coli infection. The startup's Omnii model generated new viral genes altering T7 leg shapes. The FDA authorized the trial, though the research remains unpublished and unpeer-reviewed.
Tap to vote and see what everyone thinks.
Summary by ByteBrief